E Gregora

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 231 citations · Full text

Regenerative Medicine, Cell Therapy, Transplantation +7

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis

Tomáš Kozák, Eva Havrdová, Jiří Piťha et al. · Bone Marrow Transplantation · 2000 · 109 citations

High-dose Immunosuppressive Therapy, Autoimmune Disease, Immunosuppressive Therapy +11

Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study

Robert Pytlík, Petr Beneš, M Pat'orková et al. · Bone Marrow Transplantation · 2002 · 107 citations · Full text

Transplantation, Autologous Transplant Patients, Transplantation Medicine +5

Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis

Tomáš Kozák, Eva Havrdová, Jiří Piťha et al. · Transplantation Proceedings · 2001 · 29 citations

Cell Therapy, Immunoablative Therapy, Transplantation +10